Saffron Walden, United Kingdom

Amanda Jackson

This inventor holds 1 USPTO granted patent. Top assignee: Illumina Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amanda Jackson. Retrieved from https://idiyas.com/inventor/amanda-jackson-a86nn44f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amanda Jackson - Innovator in Nucleotide Technology

Introduction

Amanda Jackson is a notable inventor based in Saffron Walden, GB. She has made significant contributions to the field of biotechnology, particularly in the area of nucleotide technology. Her work has implications for various applications in genetic research and molecular biology.

Latest Patents

Amanda holds a patent for "Purifying and Polymerizing 3'-Blocked Nucleotides." This innovation showcases her expertise in developing methods that enhance the efficiency and effectiveness of nucleotide processing.

Career Highlights

Amanda is currently employed at Illumina Corporation, a leading company in the field of genomics. Her role at Illumina allows her to work on cutting-edge technologies that advance genetic research and diagnostics.

Collaborations

Amanda collaborates with Kim Schneider, a fellow innovator in the field. Together, they contribute to the development of new technologies that push the boundaries of genetic research.

Conclusion

Amanda Jackson is a pioneering inventor whose work in nucleotide technology is shaping the future of genetic research. Her contributions are vital to advancements in biotechnology and molecular biology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…